“…Most studies assessed IPV in the third trimester (18 of 47, 38.3%; Budhathoki et al, 2013; Dennis & Vigod, 2013; Fisher, Tran, Tran, et al, 2013; Gaillard et al, 2014; Gausia et al, 2009; Guyon-Harris et al, 2017; Kita et al, 2016; Ludermir et al, 2010; Malta et al, 2012; Patel et al, 2002; Peltzer et al, 2018; Robertson-Blackmore et al, 2016; Rogathi et al, 2017; Schneider et al, 2018; Tho Nhi et al, 2019; Tho Tran et al, 2018; Tiwari et al, 2008; Valentine et al, 2011) or postpartum period, with assessments ranging from delivery (e.g., McMahon et al, 2011) to 36 months postpartum (Tsai et al, 2016; 19 of 47, 40.4%; Agrawal et al, 2014; Cintora & Laurent, 2020; Dawson et al, 2019; Escriba-Aguir et al, 2013; Fisher, Tran, Biggs, et al, 2013; Flanagan et al, 2015; Guyon-Harris et al, 2017; McMahon et al, 2011; Ogbonnaya et al, 2013; Okafor et al, 2018; Peltzer et al, 2018; Robertson-Blackmore et al, 2016; Schneider et al, 2018; Sumner et al, 2012; Tiwari et al, 2008; Tsai et al, 2016; Velonis et al, 2017; Woolhouse et al, 2012; Zhang et al, 2012). Some studies assessed IPV exposure in the second or third trimester (5 of 47, 10.6%; Bitew et al, 2019; Jackson et al, 2015; Katon et al, 2014; Nongrum et al, 2014; Valentine et al, 2011) or specifically focused on the second trimester of pregnancy (9 of 47, 19.2%; Fisher, Tran, Biggs, et al, 2013; Fisher, Tran, Tran, et al, 2013; Flach et al, 2011; …”